Study guide
6.1 Rights of Medication Administration & High-Alert Medications
Singapore Nursing Board SNB
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Legal Framework & Regulatory Governing of Nursing in Singapore
1.1 Nurses and Midwives Act & SNB Regulatory Powers 1.2 Scope of Professional Nursing Practice & Accountability 1.3 Informed Consent, Confidentiality & PDPA in Healthcare
2 Chapter 2: Ethical Standards & Professional Code of Conduct
2.1 SNB Code for Nurses and Midwives & Ethical Principles 2.2 Patient Rights, Advocacy & End-of-Life Ethical Decision-Making 2.3 Safeguarding Vulnerable Patients & Mandatory Reporting
3 Chapter 3: Holistic Patient Assessment & Nursing Process
3.1 Comprehensive Physical Assessment & Vital Signs Monitoring 3.2 Early Warning Scores & Recognising the Deteriorating Patient 3.3 Nursing Diagnosis, Person-Centred Care Planning & Evaluation
4 Chapter 4: Communication, Documentation & Clinical Safety
4.1 Therapeutic Communication & Interpersonal Care Relationships 4.2 Clinical Documentation Standards & ISBAR Clinical Handover 4.3 Clinical Risk Management, Fall Prevention & Patient Safety Goals
5 Chapter 5: Infection Prevention & Control Standards
5.1 Standard & Transmission-Based Precautions (Infection Control) 5.2 Aseptic Technique, Surgical Hand Antisepsis & Wound Care Asepsis 5.3 Outbreak Management, Multi-Drug Resistant Organisms (MDROs) & Bio-waste
6 Chapter 6: Safe Medication Administration & Clinical Pharmacology
6.1 Rights of Medication Administration & High-Alert Medications 6.2 Dosage Calculations, Unit Conversions & Pediatric/Geriatric Adjustments 6.3 Pharmacokinetics, Adverse Drug Reactions & Poison Management 6.4 Medication Reconciliation, Storage & Controlled Substances Act in SG
7 Chapter 7: Intravenous Therapy, Fluid & Electrolyte Management
7.1 Fluid Balance, Electrolyte Disturbances & ABG Interpretation 7.2 Peripheral & Central Venous Line Access, Care & Complications 7.3 Blood Product Transfusion Standards, Safety & Adverse Reaction Management
8 Chapter 8: Respiratory Care & Oxygenation Management
8.1 Airway Management, Oxygen Therapy & Pulse Oximetry 8.2 Tracheostomy Care, Suctioning & Mechanical Ventilation Nursing 8.3 Nursing Care in Acute Respiratory Distress & Chronic Obstructive Pulmonary Disease
9 Chapter 9: Cardiovascular Nursing & Hemodynamic Monitoring
9.1 Cardiac Assessment, ECG Interpretation & Common Arrhythmias 9.2 Acute Coronary Syndrome, Heart Failure & Hypertensive Crises Nursing 9.3 Shock Classification, Fluid Resuscitation & Hemodynamic Monitoring
10 Chapter 10: Medical-Surgical Nursing: Gastrointestinal & Renal Systems
10.1 Enteral & Parenteral Nutrition Management 10.2 Care of Acute Abdomen, Ostomy Care & Gastrointestinal Bleeding 10.3 Acute Kidney Injury, Chronic Kidney Disease & Dialysis Nursing
11 Chapter 11: Endocrine & Metabolic Nursing Management
11.1 Diabetes Mellitus: Glycemic Control, Insulin Therapy & Complications 11.2 Management of Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.3 Thyroid, Adrenal & Pituitary Endocrine Disorders
12 Chapter 12: Neurological Nursing & Musculoskeletal Care
12.1 Neurological Assessment, Glasgow Coma Scale (GCS) & Stroke Care 12.2 Increased Intracranial Pressure (ICP) & Seizure Management 12.3 Musculoskeletal Assessment, Traction, Cast Care & Mobility Promotion
13 Chapter 13: Perioperative & Wound Management
13.1 Preoperative Assessment, Preparation & Informed Consent Verification 13.2 Intraoperative Standards, Surgical Time-Out & Anesthesia Monitoring 13.3 Postoperative Recovery, Pain Management & Wound Healing Staging
14 Chapter 14: Elder Care, Gerontological Nursing & Chronic Disease
14.1 Comprehensive Geriatric Assessment & Frailty Syndromes 14.2 Dementia, Delirium & Depression in Older Adults 14.3 Pressure Injury Prevention, Staging & Advanced Wound Dressings
15 Chapter 15: Mental Health Nursing & Psychosocial Care
15.1 Mental Health Assessment & Therapeutic Nurse-Patient Engagement 15.2 Mood Disorders, Psychosis & Crisis Intervention 15.3 Mental Health Act in Singapore, De-escalation & Patient Safety
16 Chapter 16: Palliative Care & Symptom Management
16.1 Principles of Palliative & End-of-Life Nursing Care 16.2 Pain Assessment, Opioid Titration & Breakthrough Pain Management 16.3 Advance Care Planning (ACP) & Care of the Dying Patient
17 Chapter 17: Interprofessional Collaboration & Care Coordination
17.1 Transdisciplinary Team Dynamics & Multidisciplinary Case Conferences 17.2 Care Coordination, Community Discharge Planning & Continuity of Care 17.3 Conflict Resolution & Interprofessional Communication
18 Chapter 18: Delegation, Supervision & Clinical Leadership
18.1 Principles of Delegation to Enrolled Nurses (ENs) & Ancillary Staff 18.2 Clinical Supervision, Resource Management & Ward Operations 18.3 Quality Improvement, Clinical Audit & Incident Reporting
19 Chapter 19: Evidence-Based Practice, Education & Professional Growth
19.1 Reflective Practice & SNB CPE (Continuing Professional Education) Requirements 19.2 Integrating Evidence-Based Practice (EBP) into Clinical Care 19.3 Clinical Education, Student Preceptorship & Mentorship
6.1 Rights of Medication Administration & High-Alert Medications
Key Takeaways Explain This Topic AI
The 2023 RN competencies include the Five Rights of medication administration; expanded rights are useful teaching checks rather than a separate SNB “10 Rights” statute.
High-alert medicines require layered safeguards. Follow required local independent checks; ISMP does not recommend a manual double check for every high-alert medicine in every circumstance.
An independent checker verifies the targeted components without being primed with the first person’s answer; a second signature alone is insufficient.
Use the exact insulin product, concentration and device instructions. Toujeo 300 units/mL pen insulin must not be withdrawn into a syringe.
Reconcile uncertain orders, monitor medicine-specific effects and escalate errors promptly. Administration windows, reassessment intervals and reporting processes depend on the actual medicine and current policy.
Last updated: October 2026
- 6.1 Rights of Medication Administration & High-Alert Medications
- Rights are checks within a safe medication system
The 2023 SNB RN competencies include the Five Rights : right patient, medicine, dose, route and time. They sit within assessment, pharmacological knowledge, safe preparation, administration and evaluation. Additional teaching “rights” can remind learners about documentation, indication, education, the patient’s right to refuse and evaluation of response. Different lists contain different numbers; an expanded 10-item teaching list is not a separate universally mandated SNB law.
Check What must be established
Patient Use the approved identifiers and reconcile the prescription with the actual patient; a bed number is not enough
Medicine Match the exact product, active ingredient, formulation and prescription; check allergy and contraindication information
- Dose Verify the ordered amount, units, concentration, relevant weight/renal information and calculation
- Route Confirm the prescribed route, appropriate formulation, access and device
- Time Check the schedule, last administration, clinical urgency and medicine-specific timing requirements
- Documentation Record what was actually given or omitted, when, and relevant reasons or actions
- Indication Understand why the medicine is used and whether current findings require clarification
- Education Explain relevant purpose, precautions and monitoring in a way the patient can understand
Refusal Assess and explain, respect a capable patient’s decision, and escalate/document the clinical implications
Evaluation Monitor the intended response and adverse effects at intervals appropriate to the drug and patient
Do not administer an unclear or unsafe order because the rights appear ticked. Resolve the concern with the appropriate prescriber/pharmacist and protect the patient while doing so. There is no single verified national ±30-minute administration window for every medicine, nor one reassessment interval that safely covers every IV opioid.
High-alert medicines and layered safeguards
High-alert medicines can cause serious harm when used incorrectly. A teaching mnemonic such as PINCH highlights potassium/concentrated electrolytes, insulin, narcotics/opioids, chemotherapy and heparins. Lists and mnemonic variants differ; use the institution’s current high-alert list and procedures rather than treating the mnemonic as exhaustive.
Safeguards may include restricted storage, ready-to-use concentrations, clear labelling, separation of look-alike products, standard orders, pharmacy review, barcode checks, smart-pump limits and targeted independent checks. None is infallible. A second checker cannot correct an intrinsically unsafe workflow by signing a form.
Concentrated potassium: Never administer potassium chloride concentrate as an IV push. Verify the authorised diluted preparation, concentration, rate, compatible access, pump and monitoring under the actual protocol. This section does not invent a universal ICU-only stocking rule, concentration cutoff or rate suitable for every patient.
Insulin: Distinguish rapid, short, intermediate and long-acting formulations and match timing to the prescription, nutrition and glucose monitoring. Insulin concentration and delivery device matter; do not assume every insulin uses a U-100 syringe.
Opioids: Assess sedation, breathing, pain, other sedatives and organ function. Formulation, route, prior exposure and patient response affect safe administration and monitoring.
Heparins/anticoagulants: Check the exact agent, dose units, indication, renal function and relevant bleeding/monitoring information; different products are not automatically interchangeable.
Chemotherapy: Requires the authorised protocol, patient/regimen verification, trained staff and specialised safeguards.
Product-specific insulin example
The Singapore National Drug Formulary lists Toujeo SoloStar 300 units/mL . Its product information states that the pen displays the dose in units and that insulin must not be drawn from its cartridge into a syringe , because severe overdose can result. It is not for IV administration or an insulin infusion pump. This is a concrete reason why “always use a U-100 syringe for insulin” is unsafe.
Verify the medicine’s current authorised product information and device instructions. Do not make a concentration conversion or switch products from memory; reconcile with the prescription and pharmacist/prescriber. A familiar brand name does not remove the need to verify strength and formulation.
Independent double-checking
ISMP recommends selective, correctly performed independent double checks, integrated with other safeguards. It expressly does not recommend a manual check for all high-alert medicines, all vulnerable patients or all high-risk tasks. A current local policy may nevertheless require a check for a particular activity; follow that policy and address a missing checker through the approved escalation process.
A practical sequence is:
Identify which components require independent verification under the policy: for example patient, original order, concentration, calculation, prepared amount, route, pump settings and line connection.
Each qualified practitioner checks the targeted information independently. Do not announce an expected answer such as “this is five units; agree?” before the calculation.
Compare the independent results and the actual prepared product/device with the original order. Inspecting the syringe or label is part of verification; the problem is priming or copying the first person’s conclusion.
Resolve a discrepancy before administration. Do not average conflicting calculations or sign without checking.
Complete required documentation and patient monitoring. A co-signature does not transfer either person’s accountability.
Look-alike/sound-alike errors and clinical response
Use the exact medicine name, strength and formulation. Tall Man lettering, storage separation and alerts can help where adopted, but do not constitute a single universal MOH label colour or mandatory word list. Check the original order and label rather than relying on packaging colour, location or a familiar vial shape.
If an error, near miss or unexpected response is discovered, assess the patient and obtain appropriate clinical help promptly. Stop or withhold the affected administration when clinically appropriate, preserve relevant information and equipment, and follow the actual incident and disclosure processes. Document the patient’s condition, care and response. Do not wait for an internal form before treating deterioration or invent a universal “report every incident within 24 hours” rule.
Primary reading
SNB RN competencies, 2023 and Code, April 2018 .
ISMP independent-double-check guidance : selective use, independent cognitive verification and layered safeguards.
Singapore NDF Toujeo product information : exact 300 units/mL pen/device conditions.